Crinetics Pharmaceuticals (CRNX) Return on Sales (2018 - 2025)
Historic Return on Sales for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Q3 2025 value amounting to 909.73%.
- Crinetics Pharmaceuticals' Return on Sales fell 6469600.0% to 909.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 275.37%, marking a year-over-year decrease of 126000.0%. This contributed to the annual value of 286.26% for FY2024, which is 2341300.0% down from last year.
- Crinetics Pharmaceuticals' Return on Sales amounted to 909.73% in Q3 2025, which was down 6469600.0% from 112.18% recorded in Q2 2025.
- Crinetics Pharmaceuticals' 5-year Return on Sales high stood at 10.74% for Q1 2022, and its period low was 909.73% during Q3 2025.
- Its 5-year average for Return on Sales is 168.94%, with a median of 99.93% in 2022.
- Per our database at Business Quant, Crinetics Pharmaceuticals' Return on Sales soared by 10131400bps in 2021 and then crashed by -6469600bps in 2025.
- Quarter analysis of 5 years shows Crinetics Pharmaceuticals' Return on Sales stood at 28.58% in 2021, then plummeted by -125bps to 64.39% in 2022, then increased by 19bps to 52.12% in 2023, then tumbled by -449bps to 286.29% in 2024, then plummeted by -218bps to 909.73% in 2025.
- Its Return on Sales stands at 909.73% for Q3 2025, versus 112.18% for Q2 2025 and 267.51% for Q1 2025.